EVAX

Evaxion A/S

Healthcare · Biotechnology

$298.43 sample

+2.75 (+0.93%) 1D

Market cap

$1.09T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$298.43 +11.67% 3M daily closessample

305.21262.86

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC10-Q filed
Sep 25SECForm 144 filed
Sep 21INSInsider sell: Chief Executive Officer
Sep 10INSInsider buy: General Counsel
Sep 03SECDEF 14A filed
Aug 25INSInsider sell: EVP, Operations
Aug 14INSInsider sell: Chief Financial Officer
Aug 11INSInsider buy: Chief Executive Officer

Sign up to see the real EVAX record →

Company facts

SEC EDGAR registration

Name: Evaxion A/S
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -23sample, -100 to +100
Reporting currency: USD

Who is positioning in EVAX

sample

Insiders: 6 insider transactions over 90 days, net selling, $123.1M
Congress: No member trades over 90 days
Institutions · 13F: 24 funds hold $10.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$70.1B +17.4% y/y

Q4 2024Q3 2026

Inventory$42.1B +6.4% y/y

Q4 2024Q3 2026

Accounts receivable$32.5B +18.1% y/y

Q4 2024Q3 2026

Total debt$84.8B +8.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $654.5B +15.5% 3M
Sample peer B: $1.02T +2.8% 3M
Sample peer C: $273.1B -11.1% 3M
Sample peer D: $739.1B +12.8% 3M
Sample peer E: $837.7B +3.3% 3M